Persisters: a distinct physiological state of E. coli

BackgroundBacterial populations contain persisters, phenotypic variants that constitute approximately 1% of cells in stationary phase and biofilm cultures. Multidrug tolerance of persisters is largely responsible for the inability of antibiotics to completely eradicate infections. Recent progress in understanding persisters is encouraging, but the main obstacle in understanding their nature was our inability to isolate these elusive cells from a wild-type population since their discovery in 1944.ResultsWe hypothesized that persisters are dormant cells with a low level of translation, and used this to physically sort dim E. coli cells which do not contain sufficient amounts of unstable GFP expressed from a promoter whose activity depends on the growth rate. The dim cells were tolerant to antibiotics and exhibited a gene expression profile distinctly different from those observed for cells in exponential or stationary phases. Genes coding for toxin-antitoxin module proteins were expressed in persisters and are likely contributors to this condition.ConclusionWe report a method for persister isolation and conclude that these cells represent a distinct state of bacterial physiology.

[1]  T. Hayashi,et al.  Gene product identification and promoter analysis of hig locus of plasmid Rts1. , 1996, Biochemical and biophysical research communications.

[2]  M. Kivisaar,et al.  Effects of Combination of Different −10 Hexamers and Downstream Sequences on Stationary-Phase-Specific Sigma Factor ςS-Dependent Transcription in Pseudomonas putida , 2000, Journal of bacteriology.

[3]  Klavs F. Jensen,et al.  Gene expression analysis of Escherichia coli grown in miniaturized bioreactor platforms for high-throughput analysis of growth and genomic data , 2005, Applied Microbiology and Biotechnology.

[4]  J. Costerton,et al.  Bacterial biofilms: a common cause of persistent infections. , 1999, Science.

[5]  I. Chopra,et al.  Joint Tolerance to β-Lactam and Fluoroquinolone Antibiotics in Escherichia coli Results from Overexpression of hipA , 1998, Antimicrobial Agents and Chemotherapy.

[6]  M. Ohnishi,et al.  A new plasmid-encoded proteic killer gene system: cloning, sequencing, and analyzing hig locus of plasmid Rts1. , 1996, Biochemical and biophysical research communications.

[7]  R. Sauer,et al.  Toxin-Antitoxin Pairs in Bacteria Killers or Stress Regulators? , 2003, Cell.

[8]  G. Jacoby,et al.  Mechanism of plasmid-mediated quinolone resistance , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  K. Lewis,et al.  Biofilms and Planktonic Cells of Pseudomonas aeruginosa Have Similar Resistance to Killing by Antimicrobials , 2001, Journal of bacteriology.

[10]  K. Lewis,et al.  Persister cells and tolerance to antimicrobials. , 2004, FEMS microbiology letters.

[11]  T. Wood,et al.  Gene expression in Escherichia coli biofilms , 2004, Applied Microbiology and Biotechnology.

[12]  D. Belin,et al.  Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter , 1995, Journal of bacteriology.

[13]  K. Gerdes,et al.  Prokaryotic toxin–antitoxin stress response loci , 2005, Nature Reviews Microbiology.

[14]  Anthony Maxwell,et al.  A Fluoroquinolone Resistance Protein from Mycobacterium tuberculosis That Mimics DNA , 2005, Science.

[15]  H. Moyed,et al.  hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis , 1983, Journal of bacteriology.

[16]  G. Jacoby,et al.  Interaction of the Plasmid-Encoded Quinolone Resistance Protein QnrA with Escherichia coli Topoisomerase IV , 2005, Antimicrobial Agents and Chemotherapy.

[17]  John Quackenbush Microarray data normalization and transformation , 2002, Nature Genetics.

[18]  Måns Ehrenberg,et al.  The Bacterial Toxin RelE Displays Codon-Specific Cleavage of mRNAs in the Ribosomal A Site , 2003, Cell.

[19]  R. Gourse,et al.  Growth rate-dependent control of the rrnB P1 core promoter in Escherichia coli , 1994, Journal of bacteriology.

[20]  Jason M. Brown,et al.  A Novel Family of Escherichia coli Toxin-Antitoxin Gene Pairs , 2003, Journal of bacteriology.

[21]  Mitsuhiko Ikura,et al.  MazF cleaves cellular mRNAs specifically at ACA to block protein synthesis in Escherichia coli. , 2003, Molecular cell.

[22]  K. Gerdes,et al.  RelE toxins from Bacteria and Archaea cleave mRNAs on translating ribosomes, which are rescued by tmRNA , 2003, Molecular microbiology.

[23]  Jerry Li,et al.  Within the fold: assessing differential expression measures and reproducibility in microarray assays , 2002, Genome Biology.

[24]  A. Khodursky,et al.  Genome-wide localization of mobile elements: experimental, statistical and biological considerations , 2005, BMC Genomics.

[25]  K. Lewis,et al.  Riddle of Biofilm Resistance , 2001, Antimicrobial Agents and Chemotherapy.

[26]  V. Arcus,et al.  The PIN-domain toxin-antitoxin array in mycobacteria. , 2005, Trends in microbiology.

[27]  B. Palsson,et al.  An expanded genome-scale model of Escherichia coli K-12 (iJR904 GSM/GPR) , 2003, Genome Biology.

[28]  A. Khodursky,et al.  Escherichia coli spotted double-strand DNA microarrays: RNA extraction, labeling, hybridization, quality control, and data management. , 2003, Methods in molecular biology.

[29]  H. Nikaido,et al.  Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa , 1995, Antimicrobial agents and chemotherapy.

[30]  K. Gerdes,et al.  Rapid induction and reversal of a bacteriostatic condition by controlled expression of toxins and antitoxins , 2002, Molecular microbiology.

[31]  P. Stewart,et al.  Mechanisms of antibiotic resistance in bacterial biofilms. , 2002, International journal of medical microbiology : IJMM.

[32]  B. R. Levin,et al.  Phenotypic Tolerance: Antibiotic Enrichment of Noninherited Resistance in Bacterial Populations , 2005, Antimicrobial Agents and Chemotherapy.

[33]  Monica Riley,et al.  GenProtEC: an updated and improved analysis of functions of Escherichia coli K-12 proteins , 2004, Nucleic Acids Res..

[34]  J. Bigger TREATMENT OF STAPHYLOCOCCAL INFECTIONS WITH PENICILLIN BY INTERMITTENT STERILISATION , 1944 .

[35]  K. Gerdes,et al.  Toxin–antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes , 2005, Nucleic acids research.

[36]  N. Pride,et al.  Treatment of Staphylococcal Infections with Methicillin , 1962, British medical journal.

[37]  B. Christensen,et al.  Distribution of Bacterial Growth Activity in Flow-Chamber Biofilms , 1999, Applied and Environmental Microbiology.

[38]  N R Cozzarelli,et al.  Analysis of topoisomerase function in bacterial replication fork movement: use of DNA microarrays. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Thomas K. Wood,et al.  Autoinducer 2 Controls Biofilm Formation in Escherichia coli through a Novel Motility Quorum-Sensing Regulator (MqsR, B3022) , 2006, Journal of bacteriology.

[40]  S. Leibler,et al.  Bacterial Persistence as a Phenotypic Switch , 2004, Science.

[41]  R. Gourse,et al.  DNA determinants of rRNA synthesis in E. coli: Growth rate dependent regulation, feedback inhibition, upstream activation, antitermination , 1986, Cell.

[42]  K. Lewis,et al.  Specialized Persister Cells and the Mechanism of Multidrug Tolerance in Escherichia coli , 2004, Journal of bacteriology.